Article Sidebar
Published:
Jul 7, 2021Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Polydatin ameliorates renal fibrosis in a streptozotocin–induced rat model of diabetic nephropathy by inhibiting TLR4/NF-κB signaling
Abstract
Purpose: To determine the effects of polydatin (PD) on a streptozotocin (STZ)-induced rat model of diabetic nephropathy (DN) and NRK-52E cells treated with high glucose (HG).
Methods: Sprague Dawley rats received 65 mM STZ to model DN in vivo. NRK-52E cells were treated with HG, to model DN in vitro. Both models were treated with PD. Fasting blood glucose, kidney/body weight, urinary protein, serum creatinine, and blood urea nitrogen levels, interstitial injury score, as well as protein expression levels of connective tissue growth factor (CTGF), fibronectin, and collagen I were determined in DN rats after PD treatment. Enzyme-linked immunosorbent assay was used to measure inflammatory factors. Protein expression was determined by Western blot analysis while apoptosis was assessed by flow cytometry.
Results: STZ successfully induced DN in rats. PD treatment significantly reduced kidney/body weight; decreased fasting blood glucose, urinary protein, serum creatinine, and blood urea nitrogen levels; lowered interstitial injury scores; and downregulated protein expression levels of CTGF, fibronectin, and collagen I. It also inhibited inflammatory reaction and suppressed Toll-like receptor (TLR4)/nuclear factor (NF)-κB signaling. Furthermore, PD suppressed apoptosis, reduced inflammatory factor levels, and suppressed TLR4/NF-κB signaling induced by HG in NRK-52E cells.
Conclusion: PD exerts a protective role in DN by decreasing interstitial injury, reducing renal fibrosis, inhibiting inflammatory responses, and suppressing cell apoptosis, at least, partly via inactivation of TLR4/ NF-κB pathway.
